The Center consists of a multi-disciplinary team actively involved in study design, recruitment, database creation and management, biostatistical analysis and reporting for research studies in migraine, hypertension, breast, skin and prostate cancer, osteoporosis and multiple sclerosis.
Our aims are to design and manage clinical trials to provide substantiated, statistically relevant data regarding the effectiveness of health interventions. We provide support for large and small companies or independent investigators involved in clinical trials. Trials are conducted in order to meet the unique research goals and specific objectives of each company, in a cost-effective and timely fashion.
We offer a range of clinical trial services that can be customized to fit the needs of each study. We are dedicated to the highest quality clinical trial services. With an in-depth knowledge of Good Clinical Practice/ International Conference on Harmonisation and Food and Drug Authority guidelines, trials are undertaken in accordance with scientific and regulatory requirements, as well as meeting company objectives, and ethical standards for research.
Trial Management Services
- Study design
- Protocol and Clinical Report Form design
- Investigator and participant recruitment and training
- Ethics submissions
- Trial implementation
- Full monitoring service
- Data management
- Statistical analysis and reporting
- Laboratory, Radiological and Day Theatre facilities available
Clinical Trials Service
- Study design and development
- Recruitment and training
- Ethics submissions
- Trial implementation
- Full monitoring service
- Data management and validation
- Statistical randomization analysis and reporting
Health Trial Services for
- Pharmaceutical Industry
- Complementary Therapies
- Product Testing and Quality Control
- Genomics Analysis
- Medication Responses
Outcome
To provide substantiated, statistically relevant data regarding the effectiveness of specific health interventions, in a timely and cost-effective manner.
Previous study partners
GlaxoSmithKline (UK), Gemini Genomics Pty Ltd (UK), Neem Developments Pty Ltd (Australia)